PRIME Archives -

An early-stage drug candidate for hard-to-treat brain tumours has been granted special ‘PRIME’ status by the European Medicines

Tocagen’s brain tumour candidate gets PRIME designation

https://pharmaphorum.com/news/tocagens-brain-tumour-treatment-gets-prime-designation/

Latest addition to EMA’s fast-track for cutting edge drugs

Immunotherapy for brain cancer gets European PRIME status

https://pharmaphorum.com/news/immunotherapy-brain-cancer-gets-european-prime-status/

Andrew McConaghie reports on a newly-launched plan to speed up access to groundbreaking new medicines in Europe.

Europe launches new PRIME fast-track for promising medicines

https://pharmaphorum.com/articles/europe-launches-new-prime-fast-track-for-promising-medicines/

PRIME